On January 31, 2025, the company amended its Receivables Purchase Agreement through the 1st amendment, the RPA Amendment, which increased the facility limit from $300 million to $700 million.

1. 01

   On January 31, 2025, the company amended its Receivables Purchase Agreement through the 1st amendment, the RPA Amendment, which increased the facility limit from $300 million to $700 million.

2. 02

   The company said The Toronto-Dominion Bank joined as a committed purchaser with a scheduled commitment termination date of January 30, 2026. It said the scheduled commitment termination date of August 23, 2027 for the other committed purchasers was not changed.

3. 03

   Labcorp said MUFG Bank Ltd. and its related conduit purchasers joined as purchasers, and that their loans or investments may accrue interest at the CP Rate plus an applicable margin. It said the interest rate for all other purchasers was unchanged at a daily SOFR or term SOFR rate plus a 0.10% SOFR adjustment, or a base rate, in each case plus an applicable margin.

4. 04

   Labcorp said Labcorp Receivables LLC is a separate legal entity with its own creditors, so its assets are not available to pay Labcorp's creditors or those of its other subsidiaries. It said collections from the receivables in excess of amounts needed to repay the purchasers and other Labcorp Receivables creditors may be remitted to Labcorp.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.